Review Article

The New (2018) European Hypertension Guidelines an overview & comments

Mohsen Ibrahim M*

Published: 24 July, 2019 | Volume 3 - Issue 1 | Pages: 039-042

The European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) jointly developed a series of hypertension guidelines in the years 2003, 207 and 2013. The most recent guidelines were issued by the two societies in August this year (2018) and were published in the European Heart Journal. The new guidelines are printed in more than 90 pages and cover almost all aspects of hypertension based on extensive review of literature giving highest priority to data from randomized controlled trials and well conducted meta-analysis. In important areas where there is inadequate or no evidence, guidelines authors resort to expert opinion. The text was developed over approximately 24 months and was reviewed by representatives of ESC and ESH national hypertension societies. Although it is less than five years since the last hypertension European guidelines in 2013, the recent 2018 guidelines show important differences in diagnosis and treatment strategies with the addition of new sections and recommendations on management of hypertensive emergencies, hypertension in women and pregnancy, different ethnic groups, chronic obstructive pulmonary disease, cancer therapies, peri-operative management, sexual dysfunction and perioperative management.

Read Full Article HTML DOI: 10.29328/journal.ach.1001017 Cite this Article Read Full Article PDF


  1. Bryan W, Giuseppe M, Wilko S, Enrico A, Michel Azizi Michel Burnier, Denis L Clement, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. 2018; 39: 3021–3104.
  2. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387: 957-967. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26724178
  3. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses. J Hypertens. 2015; 33: 1321-1341. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26039526
  4. The SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373: 2103-2116.
  5. Sundström J, Arima H, Jackson R, Turnbull F, Rahimi K, et al. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med. 2015; 162: 184-191. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25531552
  6. Ibrahim MM. Hypertension in Developing Countries: A major challenge for the future. Curr Hypertens Rep. 2018; 20: 38. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29717393
  7. Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017; 33: 557-576. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28449828
  8. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, et al. Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol. 2018; 34: 506–525. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29731013
  9. Ibrahim, M.M. The Egyptian hypertension society: Egyptian hypertension guidelines. Egyptian Heart Journal. 2014; 66: 79-132.

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?